Reshuffle backlash to challenge KPMA unity

As the proposed revision of article of incorporation in the Korea Pharmaceutical Manufacturers Association has failed to attract any support from many members of small- and medium-sized pharmaceutical firms, the KPMA is facing a potential crisis that could trigger a dispute between large and small drugmakers.

Analysts say the growing furor over the issue could also hurt KPMA’s efforts to bui...